Guofeng Zhou

1.0k total citations
48 papers, 786 citations indexed

About

Guofeng Zhou is a scholar working on Hepatology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Guofeng Zhou has authored 48 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 14 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Guofeng Zhou's work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Renal cell carcinoma treatment (5 papers). Guofeng Zhou is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Renal cell carcinoma treatment (5 papers). Guofeng Zhou collaborates with scholars based in China and United States. Guofeng Zhou's co-authors include Chuansheng Zheng, Xiangliang Yang, Yanbing Zhao, Gansheng Feng, Bin Xiong, Qing Du, Hui Zhao, Huibi Xu, Xuefeng Kan and Laisheng Chou and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Advanced Functional Materials.

In The Last Decade

Guofeng Zhou

47 papers receiving 775 citations

Peers

Guofeng Zhou
Hongbo Gao China
Hongjun Yuan China
Yujie Su China
Jingjie Hu United States
Yuanyi Zheng China
Xing Huang China
Yuan Yu China
Sanshiro Hanada Japan
Qunqun Bao China
Hongbo Gao China
Guofeng Zhou
Citations per year, relative to Guofeng Zhou Guofeng Zhou (= 1×) peers Hongbo Gao

Countries citing papers authored by Guofeng Zhou

Since Specialization
Citations

This map shows the geographic impact of Guofeng Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guofeng Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guofeng Zhou more than expected).

Fields of papers citing papers by Guofeng Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guofeng Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guofeng Zhou. The network helps show where Guofeng Zhou may publish in the future.

Co-authorship network of co-authors of Guofeng Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Guofeng Zhou. A scholar is included among the top collaborators of Guofeng Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guofeng Zhou. Guofeng Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Yusheng, Yi Li, Jing Wang, et al.. (2024). Immune checkpoint inhibitors in cancer: the increased risk of atherosclerotic cardiovascular disease events and progression of coronary artery calcium. BMC Medicine. 22(1). 44–44. 12 indexed citations
2.
Jiang, Shanshan, Yi Li, Yusheng Guo, et al.. (2024). MRI-measured periprostatic to subcutaneous adipose tissue thickness ratio as an independent risk factor in prostate cancer patients undergoing radical prostatectomy. Scientific Reports. 14(1). 20896–20896. 1 indexed citations
3.
Li, Yi, Yusheng Guo, Lin Li, et al.. (2024). Bone mineral density as an individual prognostic biomarker in NSCLC patients treated with immune checkpoint inhibitors. Frontiers in Immunology. 15. 1332303–1332303. 3 indexed citations
4.
Li, Jing, Yan Zou, Xiangchuang Kong, et al.. (2023). Exploring functional connectivity alterations in sudden sensorineural hearing loss: A multilevel analysis. Brain Research. 1824. 148677–148677. 3 indexed citations
5.
Wang, Wei, Yanqiao Ren, Fuquan Wang, et al.. (2022). Arterial enhancement fraction in evaluating the therapeutic effect and survival for hepatocellular carcinoma patients treated with DEB-TACE. Cancer Imaging. 22(1). 38–38. 6 indexed citations
6.
Liu, Ziyi, Xuefeng Kan, Lijie Zhang, et al.. (2022). Transarterial Chemoembolization Combined with Apatinib for Treatment of Advanced Hepatocellular Carcinoma: Analysis of Survival and Prognostic Factors. Current Medical Science. 42(5). 1015–1021. 3 indexed citations
7.
Wang, Qi, Hui Zhang, Qianqian Ren, et al.. (2021). Sublethal hyperthermia enhances anticancer activity of doxorubicin in chronically hypoxic HepG2 cells through ROS-dependent mechanism. Bioscience Reports. 41(6). 4 indexed citations
8.
9.
Liang, Bin, Hua Xiang, Cong Ma, et al.. (2020). <p>Comparison of chemoembolization with CalliSpheres® microspheres and conventional chemoembolization in the treatment of hepatocellular carcinoma: a multicenter retrospective study</p>. Cancer Management and Research. Volume 12. 941–956. 22 indexed citations
10.
Wang, Xinquan, et al.. (2020). Value of T1 mapping on gadoxetic acid-enhanced MRI for microvascular invasion of hepatocellular carcinoma: a retrospective study. BMC Medical Imaging. 20(1). 43–43. 14 indexed citations
11.
Kan, Xuefeng, Bin Liang, Guofeng Zhou, et al.. (2020). Transarterial Chemoembolization Combined With Apatinib for Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis. Frontiers in Oncology. 10. 970–970. 33 indexed citations
12.
Wang, Yong, Guofeng Zhou, Dong Liu, et al.. (2017). Strategy of endovascular treatment for renal artery aneurysms. Clinical Radiology. 73(4). 414.e1–414.e5. 7 indexed citations
13.
Kan, Xuefeng, Yong Wang, Bin Xiong, et al.. (2016). Radiofrequency ablation combined with transarterial chemoembolization for liver metastases from gastrointestinal cancers. Journal of Huazhong University of Science and Technology [Medical Sciences]. 36(2). 200–204. 5 indexed citations
14.
Liu, Yiming, et al.. (2016). Screening and identification of a specific peptide for targeting hypoxic hepatoma cells. Molecular and Cellular Probes. 30(4). 246–253. 4 indexed citations
15.
Duan, Xuhua, Jianzhuang Ren, Guofeng Zhou, et al.. (2015). Clinical Features and Endovascular Treatment of Visceral Artery Pseudoaneurysms. Annals of Vascular Surgery. 29(3). 482–490. 12 indexed citations
16.
Liang, Bin, Han‐Ping Wu, Yong Wang, et al.. (2013). Effect of Transcatheter Intraarterial Therapies on the Distribution of Doxorubicin in Liver Cancer in a Rabbit Model. PLoS ONE. 8(10). e76388–e76388. 26 indexed citations
17.
Wu, Guangyao, Xiangquan Kong, Guofeng Zhou, et al.. (2012). Resting-state, functional MRI on regional homogeneity changes of brain in the heavy smokers. Zhonghua fangshexian yixue zazhi. 46(3). 215–219. 1 indexed citations
18.
19.
Tang, Jinglong, Ling Xiong, Guofeng Zhou, et al.. (2010). Silver Nanoparticles Crossing Through and Distribution in the Blood-Brain Barrier In Vitro. Journal of Nanoscience and Nanotechnology. 10(10). 6313–6317. 118 indexed citations
20.
Xiong, Bin, Gansheng Feng, Shihua Luo, et al.. (2008). Changes of CD4+ CD25+ regulatory T cells in peripheral blood in patients with hepatocellular carcinoma before and after TACE. Journal of Huazhong University of Science and Technology [Medical Sciences]. 28(6). 645–648. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongbo Gao Breakdown of academic impact, for papers by Hongjun Yuan Breakdown of academic impact, for papers by Yujie Su Breakdown of academic impact, for papers by Jingjie Hu Breakdown of academic impact, for papers by Yuanyi Zheng Breakdown of academic impact, for papers by Xing Huang Breakdown of academic impact, for papers by Yuan Yu Breakdown of academic impact, for papers by Sanshiro Hanada Breakdown of academic impact, for papers by Qunqun Bao
Rankless by CCL
2026